Baird Starts Medpace (MEDP) at Neutral
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/26/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Tweet
Share
E-mailGet Alerts MEDP Hot Sheet
Price: $669.20 --0%
Rating Summary:
4 Buy, 16 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 8 | Down: 13 | New: 20
Rating Summary:
4 Buy, 16 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 8 | Down: 13 | New: 20
Join SI Premium – FREE
Baird initiated coverage on Medpace (NASDAQ: MEDP) with a Neutral rating and a price target of $35.00.
For an analyst ratings summary and ratings history on Medpace click here. For more ratings news on Medpace click here.
Shares of Medpace closed at $30.70 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Citizens Starts Oaktree Specialty Lending Corp (OCSL) at Market Perform
- Medpace (MEDP) PT Raised to $675 at Barclays
- Medpace beats Q3 estimates but guides below on revenue
Create E-mail Alert Related Categories
New CoverageRelated Entities
Robert W BairdSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
